Infectious diseases are some of the deadliest diseases that pose a significant risk to human life. Since the advent of the pandemic, scientists worldwide have intensified research and development of preventative vaccines that will hopefully combat existing and new infectious disease threats. Because of this dedicated focus, the global market for human preventive vaccines experienced […]
The U.S. Rx-to-OTC market has grown into a $13,807 million ($13.8 billion) market, according to 2021 estimates by leading medical market researcher Kalorama Information in the new report The Market for Rx-to-OTC Switches, 8th Edition. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness […]
Not since the Swine Flu epidemic of 2009 has there been this amount of emphasis on vaccines and vaccine development. This new infectious disease threat with no anti-viral, nor vaccine is causing significant concern among healthcare providers, governments and the public. Last-resort measures such as school closings and curfews in place in the United States […]
News of an approval of a biosimilar for a major Roche cancer drug is, we think, evidence that U.S. biosimilars are a growth market opportunity. At the same time, the approval is a growth limiter for booming cancer drug markets. Pfizer Inc confirmed Friday that the the FDA approved its biosimilar to Avastin. Pfizer’s Zirabev […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
